These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The impact of HTA and procurement practices on the selection and prices of medical devices. Callea G; Armeni P; Marsilio M; Jommi C; Tarricone R Soc Sci Med; 2017 Feb; 174():89-95. PubMed ID: 28013109 [TBL] [Abstract][Full Text] [Related]
5. Report on financing the new model of family medicine. Spann SJ; Ann Fam Med; 2004 Dec; 2 Suppl 3(Suppl 3):S1-21. PubMed ID: 15654084 [TBL] [Abstract][Full Text] [Related]
6. [Benefit assessments for medical technology devices: Strategic challenges for clinical research]. Schönermark MP HNO; 2015 Aug; 63(8):586-8. PubMed ID: 26204843 [No Abstract] [Full Text] [Related]
7. Assessment of medical devices: how to conduct comparative technology evaluations of product performance. Burns LR; Bradlow ET; Lee JA; Antonacci AC Int J Technol Assess Health Care; 2007; 23(4):455-63. PubMed ID: 17937834 [TBL] [Abstract][Full Text] [Related]
8. ASSESSING THE VALUE OF INNOVATIVE MEDICAL DEVICES AND DIAGNOSTICS: THE IMPORTANCE OF CLEAR AND RELEVANT CLAIMS OF BENEFIT. Campbell B; Campbell M; Dobson L; Higgins J; Dillon B; Marlow M; Pomfrett CJD Int J Technol Assess Health Care; 2018 Jan; 34(4):419-424. PubMed ID: 30025548 [TBL] [Abstract][Full Text] [Related]
9. A review of the economic tools for assessing new medical devices. Craig JA; Carr L; Hutton J; Glanville J; Iglesias CP; Sims AJ Appl Health Econ Health Policy; 2015 Feb; 13(1):15-27. PubMed ID: 25139635 [TBL] [Abstract][Full Text] [Related]
11. Economic evaluation approaches for new technology. Papatheofanis FJ IEEE Eng Med Biol Mag; 2003; 22(3):16-7. PubMed ID: 12845811 [No Abstract] [Full Text] [Related]
12. Role of technology assessment in health benefits coverage for medical devices. Braslow NM; Shatin D; McCarthy DB; Newcomer LN Am J Manag Care; 1998 Sep; 4 Spec No():SP139-50. PubMed ID: 10185990 [TBL] [Abstract][Full Text] [Related]
13. Evolving reimbursement and pricing policies for devices in Europe and the United States should encourage greater value. Sorenson C; Drummond M; Burns LR Health Aff (Millwood); 2013 Apr; 32(4):788-96. PubMed ID: 23569060 [TBL] [Abstract][Full Text] [Related]
14. Will Some Manufacturers Never Learn? Lynch PK Biomed Instrum Technol; 2017; 51(1):82-83. PubMed ID: 28103084 [No Abstract] [Full Text] [Related]
15. From medical invention to clinical practice: the reimbursement challenge facing new device procedures and technology--part 3: payment. Raab GG; Parr DH J Am Coll Radiol; 2006 Nov; 3(11):842-50. PubMed ID: 17412183 [TBL] [Abstract][Full Text] [Related]
16. Outcomes research affecting devices. Wagner M Mod Healthc; 1991 Feb; 21(6):54. PubMed ID: 10109044 [TBL] [Abstract][Full Text] [Related]
17. Maximizing purchase decision factors other than price. Berkowitz DA; Diamond JF; Montagnolo AJ Hosp Mater Manage Q; 1992 May; 13(4):27-41. PubMed ID: 10117378 [TBL] [Abstract][Full Text] [Related]
19. The economic evaluation of medical devices: challenges. Kingkaew P; Teerawattananon Y J Med Assoc Thai; 2014 May; 97 Suppl 5():S102-7. PubMed ID: 24964706 [TBL] [Abstract][Full Text] [Related]
20. Integrating health economics modeling in the product development cycle of medical devices: a Bayesian approach. Vallejo-Torres L; Steuten LM; Buxton MJ; Girling AJ; Lilford RJ; Young T Int J Technol Assess Health Care; 2008; 24(4):459-64. PubMed ID: 18828941 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]